CAREFUSION CORP Forms 3, 4 and 5: Restricted Stock Units and Performance Rights
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 51 rows in 2011. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2011-12-08: Reporting owner Maschal Jean; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-11-10: Reporting owner Abbey Donald; Form 3; Security Restricted Stock Units; Transaction Holding.
- 2011-11-10: Reporting owner Abbey Donald; Form 3; Security Restricted Stock Units; Transaction Holding.
- 2011-11-10: Reporting owner Abbey Donald; Form 3; Security Restricted Stock Units; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2011-12-08 | Maschal Jean Officer (SVP, Chief Accounting Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −103 2,934 owned after | no price filed | 2011-12-09 | |
| 2011-11-10 holding as of filing | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 3 | Restricted Stock Units Derivative · Direct | Holding | no price filed | 2011-11-10 | ||
| 2011-11-10 holding as of filing | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 3 | Restricted Stock Units Derivative · Direct | Holding | no price filed | 2011-11-10 | ||
| 2011-11-10 holding as of filing | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 3 | Restricted Stock Units Derivative · Direct | Holding | no price filed | 2011-11-10 | ||
| 2011-11-10 holding as of filing | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 3 | Restricted Stock Units Derivative · Direct | Holding | no price filed | 2011-11-10 | ||
| 2011-11-10 holding as of filing | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 3 | Restricted Stock Units Derivative · Direct | Holding | no price filed | 2011-11-10 | ||
| 2011-11-02 | WAYMAN ROBERT PAUL Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,019 6,019 owned after | no price filed | 2011-11-03 | |
| 2011-11-02 | OHALLERAN MICHAEL D Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,019 6,019 owned after | no price filed | 2011-11-03 | |
| 2011-11-02 | MILLER EDWARD D JR Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,019 6,019 owned after | no price filed | 2011-11-03 | |
| 2011-11-02 | LUCIER GREGORY T Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,019 6,019 owned after | no price filed | 2011-11-03 | |
| 2011-11-02 | LOSH J MICHAEL Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,019 6,019 owned after | no price filed | 2011-11-03 | |
| 2011-11-02 | KOSECOFF JACQUELINE B Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,019 6,019 owned after | no price filed | 2011-11-03 | |
| 2011-11-02 | FRIEL ROBERT F Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,019 6,019 owned after | no price filed | 2011-11-03 | |
| 2011-11-02 | FRANCIS PHILIP L Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,019 6,019 owned after | no price filed | 2011-11-03 | |
| 2011-09-15 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,101 17,102 owned after | no price filed | 2011-09-19 | |
| 2011-09-15 | Maschal Jean Officer (SVP, Chief Accounting Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,760 4,993 owned after | no price filed | 2011-09-19 | |
| 2011-09-15 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,894 15,895 owned after | no price filed | 2011-09-19 | |
| 2011-09-15 | La Fortune Gordon Officer (EVP, Int'l. Commercial Ops) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,901 11,902 owned after | no price filed | 2011-09-19 | |
| 2011-09-15 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,279 18,280 owned after | no price filed | 2011-09-19 | |
| 2011-08-16 | FRIEL ROBERT F Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,533 0 owned after | no price filed | 2011-08-16 | |
| 2011-08-16 | LUCIER GREGORY T Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,533 0 owned after | no price filed | 2011-08-16 | |
| 2011-08-16 | KOSECOFF JACQUELINE B Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,533 0 owned after | no price filed | 2011-08-16 | |
| 2011-08-16 | MILLER EDWARD D JR Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,533 0 owned after | no price filed | 2011-08-16 | |
| 2011-08-16 | OHALLERAN MICHAEL D Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,533 0 owned after | no price filed | 2011-08-16 | |
| 2011-08-16 | WAYMAN ROBERT PAUL Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,533 0 owned after | no price filed | 2011-08-16 | |
| 2011-08-16 | FRANCIS PHILIP L Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,533 0 owned after | no price filed | 2011-08-16 | |
| 2011-08-16 | LOSH J MICHAEL Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,533 0 owned after | no price filed | 2011-08-16 | |
| 2011-08-16 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,879 7,760 owned after | no price filed | 2011-08-16 | |
| 2011-08-16 | Maschal Jean Officer (SVP, Chief Accounting Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,518 3,037 owned after | no price filed | 2011-08-16 | |
| 2011-08-16 | Lopez Anthony Officer (SVP and GM, Respiratory) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,418 4,836 owned after | no price filed | 2011-08-16 | |
| 2011-08-16 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,621 7,243 owned after | no price filed | 2011-08-16 | |
| 2011-08-16 | Jain Vivek Officer (Pres., Procedural Solutions) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,901 7,802 owned after | no price filed | 2011-08-16 | |
| 2011-08-16 | La Fortune Gordon Officer (EVP, International Operations) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,409 6,820 owned after | no price filed | 2011-08-16 | |
| 2011-08-16 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,236 10,474 owned after | no price filed | 2011-08-16 | |
| 2011-08-15 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,212 0 owned after | no price filed | 2011-08-16 | |
| 2011-08-15 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,087 10,087 owned after | no price filed | 2011-08-16 | |
| 2011-08-15 | Maschal Jean Officer (SVP, Chief Accounting Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,190 0 owned after | no price filed | 2011-08-16 | |
| 2011-08-15 | Maschal Jean Officer (SVP, Chief Accounting Officer) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,944 3,944 owned after | no price filed | 2011-08-16 | |
| 2011-08-15 | MARCHETTI ROGER Officer (EVP, Human Resources) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +26,066 26,066 owned after | no price filed | 2011-08-16 | |
| 2011-08-15 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,258 0 owned after | no price filed | 2011-08-16 | |
| 2011-08-15 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,162 11,162 owned after | no price filed | 2011-08-16 | |
| 2011-08-15 | Jain Vivek Officer (Pres., Procedural Solutions) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,820 0 owned after | no price filed | 2011-08-16 | |
| 2011-08-15 | Jain Vivek Officer (Pres., Procedural Solutions) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,711 11,711 owned after | no price filed | 2011-08-16 | |
| 2011-08-15 | La Fortune Gordon Officer (EVP, International Operations) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,733 0 owned after | no price filed | 2011-08-16 | |
| 2011-08-15 | La Fortune Gordon Officer (EVP, International Operations) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,933 5,933 owned after | no price filed | 2011-08-16 | |
| 2011-08-15 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,736 0 owned after | no price filed | 2011-08-16 | |
| 2011-08-15 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,347 23,347 owned after | no price filed | 2011-08-16 | |
| 2011-08-15 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +73,357 73,357 owned after | no price filed | 2011-08-16 | |
| 2011-07-15 | Leonard Thomas J Officer (President, Dispensing Tech.) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,468 0 owned after | no price filed | 2011-07-18 | |
| 2011-02-15 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +380,029 380,029 owned after | no price filed | 2011-02-17 | |
| 2011-02-15 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Performance Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +450,094 450,094 owned after | no price filed | 2011-02-17 |